- Active Ingredients
Product Documentation
-
View RMM (Risk of miscarriage and birth defects: Patient Guide)
Last updated on this site: 10 May 2024
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintMycophenolate mofetil 500mg Film-coated Tablets
- PL Number:
- 20075/0001
- MA Holder:
- Accord Healthcare Limited
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Patient Information Leaflet (PIL - Mycophenolate Mofetil 500 mg Film-coated Tablets)
Last updated on this site: 30 Nov 2023
Description of update: To update SmPC sections 4.6, 4.8, 5.1, 5.2 and 5.3 and leaflet section 2 and 3 in-line with the information of reference product (Cellcept 500mg Film-Coated Tablets, MAH: Roche Registration GmbH, Germany; EU procedure number: EMEA/H/C/000082).
PIL sections updated: Title, 1, 2, 3 and 6.
View Summary of Product Characteristics (SmPC - Mycophenolate Mofetil 500 mg Film-coated Tablets)Last updated on this site: 16 Jul 2024
To update SmPC section 4.6 to implement the wording agreed by the CHMP following the outcome of the PSUR procedure EMEA/H/C/PSUSA/10550/202305.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.